Skip to main content Accessibility help
×
Home

Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: An interim analysis

  • Kimberley P. Good (a1), Ivan Kiss (a1), Christine Buiteman (a2), Hazel Woodley (a2), Qing Rui (a2), David Whitehorn (a3) and Lili Kopala (a1)...

Abstract

Background

The efficacies of second-generation antipsychotic medications in reducing symptoms are reasonably well-documented, but their effects on cognition are less clearly understood.

Aims

To undertake an interim analysis of an open label, 2-year study examining the effects of quetiapine on cognition in patients with a first episode of schizophrenia and related disorders.

Method

Cognitive testing was performed before quetiapine was initiated and repeated after 3, 6 and 12 months of treatment. To date, 13 patients have been fully assessed (mean dose 517.9 mg/day; s.d.=225.8).

Results

Statistically significant improvement was noted on measures of attention (Continuous Performance Test; CPT), verbal productivity (Verbal Fluency Test) and executive function (Object Alternation Test) after 6 and 12 months of treatment. For the CPT, improvement was also noted after 3 months of treatment.

Conclusions

During treatment for 1 year with quetiapine, cognitive performance was improved in young patients with psychosis. Continued controlled investigations of the effects of quetiapine on cognition are desirable.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: An interim analysis
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: An interim analysis
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: An interim analysis
      Available formats
      ×

Copyright

Corresponding author

Dr Kimberley Good, Department of Psychiatry, Dalhousie University, Suite 3073-AJLB, 5909 Veterans' Memorial Lane, Halifax, Nova Scotia, Canada B3H 2E2. E-mail: kimpgood@is.dal.ca

Footnotes

Hide All

Presented in part at the European First Episode Schizophrenia Network Meeting, Whistler BC, Canada, 27 April 2001.

Declaration of interest

Partial support from AstraZeneca (unrestricted grant) and the Department of Health, Province of Nova Scotia.

Footnotes

References

Hide All
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.
Censits, D., Ragland, J., Gur, R., et al (1997) Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophrenia Research, 24, 289298.
Green, M., Marshall, B., Wirshing, W., et al (1997) Does risperidone improve verbal working memory in treatment-resistant schizophrenia? American Journal of Psychiatry, 154, 799804.
Green, M., Kern, R., Braff, D., et al (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”? Schizophrenia Bulletin, 26, 119136.
Hagger, C., Buckley, P., Kenny, J., et al (1993) Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry, 34, 702712.
Harvey, P. & Keefe, R. (2001) Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. American Journal of Psychiatry, 158, 176184.
Hoff, A., Faustman, W., Wieneke, M., et al (1996) The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic in-patients. Neuropsychopharmacology, 15, 361369.
Kane, J., Honigfeld, G., Singer, J., et al (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789796.
Kay, S. R., Fiszbein, A. & Opler, L. A. (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261276.
Keefe, R., Silva, S., Perkins, D., et al (1999) The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophrenia Bulletin, 25, 201222.
Kern, R., Green, M., Barringer, D., et al (1998) Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients. Biological Psychiatry, 44, 726732.
Kopala, L., Good, K. & Honer, W. (1997) Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low-dose risperidone. Journal of Clinical Psychopharmacology, 17, 308313.
Lee, M., Thompson, P. & Meltzer, H. (1994) Effects of clozapine on cognitive function in schizophrenia. Journal of Clinical Psychiatry, 55, 8287.
Lezak, M. (1995) Neuropsychological Assessment (3rd edn). New York: Oxford University Press.
Lussier, I. & Stip, E. (2001) Memory and attention deficits in drug naive patients with schizophrenia. Schizophrenia Research, 48, 4555.
Marder, S. & Meibach, R. (1994) Risperidone in the treatment of schizophrenia. American Journal of Psychiatry, 151, 825835.
O'Carroll, R. (1992) Neuropsychology of psychosis. Current Opinion in Psychiatry, 5, 3844.
Purdon, S., Jones, B., Stip, E., et al (2000) Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone or haloperidol. Archives of General Psychiatry, 57, 249258.
Purdon, S., Malla, A., Labelle, A., et al (2001) Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. Journal of Psychiatry and Neuroscience, 26, 137149.
Sax, K., Strakowski, S. & Keck, P. (1998) Attentional improvement following quetiapine fumarate treatment in schizophrenia. Schizophrenia Research, 33, 151155.
Saykin, A., Shtasel, D., Gur, R., et al (1994) Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Archives of General Psychiatry, 51, 124131.
Velligan, D. & Miller, A. (1999) Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment. Journal of Clinical Psychiatry, 60, 2528.

Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: An interim analysis

  • Kimberley P. Good (a1), Ivan Kiss (a1), Christine Buiteman (a2), Hazel Woodley (a2), Qing Rui (a2), David Whitehorn (a3) and Lili Kopala (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: An interim analysis

  • Kimberley P. Good (a1), Ivan Kiss (a1), Christine Buiteman (a2), Hazel Woodley (a2), Qing Rui (a2), David Whitehorn (a3) and Lili Kopala (a1)...
Submit a response

eLetters

We encountered an error trying to retrieve eLetters for this article. Please try again or contact Customer Services

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *